US 7407939
Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics
granted A61KA61K38/00A61K47/64
Quick answer
US patent 7407939 (Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics) held by CureGenics Ltd. expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CureGenics Ltd.
- Grant date
- Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/00, A61K47/64, A61P, A61P25/00